Home > Browse Issues > Vol.44 No.12

Research Progress on Leucine-Rich α2-Glycoprotein-1 in Inflammatory Diseases and Tumors


ZHAO Lingzhi, SONG Peipei, YOU Chongge*

(Laboratory Medicine Center, Lanzhou University Second Hospital, Lanzhou 730030, China)
Abstract:

LRG1 (leucine-rich α2-glycoprotein-1) is an important member of the leucine-repeat sequence protein family. LRG1 plays a key regulatory role in biological processes such as inflammation, angiogenesis, fibrosis, cell adhesion, apoptosis and cell activity. While various pathogenic mechanisms of LRG1 have been explored, its potential as a biomarker for diagnosis, prognosis and monitoring of diseases has also been extensively investigated. This article reviews the mechanisms of LRG1 in inflammatory diseases and tumors, aiming to provide a more comprehensive understanding of LRG1 and to realize the possibilities of LRG1 in clinical diagnosis and therapy.


CSTR: 32200.14.cjcb.2022.12.0015